H18.429 Band keratopathy, unspecified eye

Name of the Condition

• Band Keratopathy, Unspecified Eye
• ICD Code: H18.429

Summary

Band keratopathy, unspecified eye, is a condition characterized by the deposition of calcium salts in the cornea, forming a band-like opacity. This can lead to visual impairment, particularly if the opacity affects the visual axis. The condition may be unilateral or bilateral and is often associated with chronic ocular or systemic diseases.

Causes

The deposition of calcium in the cornea is typically linked to chronic ocular inflammation, trauma, or systemic conditions that disrupt calcium metabolism. Common underlying causes include uveitis, glaucoma, chronic keratitis, or systemic disorders such as hyperparathyroidism, renal failure, or vitamin D intoxication. Prolonged use of certain medications, such as topical corticosteroids, may also contribute.

Risk Factors

• Chronic ocular inflammation (e.g., uveitis)
• History of eye trauma or surgery
• Systemic conditions affecting calcium metabolism (e.g., renal disease, hyperparathyroidism)
• Prolonged use of topical medications, especially corticosteroids
• Advanced age

Symptoms

• Gradual loss of vision, often due to corneal opacity
• Blurred or hazy vision
• Sensitivity to light (photophobia)
• Eye discomfort or irritation
• Visible white or gray band across the cornea (may be asymptomatic initially)

Diagnosis

Diagnosis is typically made through a comprehensive eye examination, including slit-lamp biomicroscopy to visualize the corneal opacity. Additional tests, such as corneal topography or anterior segment optical coherence tomography (OCT), may be used to assess the extent of the opacity. Laboratory tests to evaluate systemic calcium metabolism (e.g., serum calcium, phosphate, parathyroid hormone levels) may be ordered if an underlying systemic cause is suspected.

Treatment Options

Treatment depends on the severity of visual impairment and the underlying cause. Mild cases may not require intervention. For symptomatic or visually significant cases, options include chelation therapy (e.g., ethylenediaminetetraacetic acid [EDTA] drops) to dissolve calcium deposits, superficial keratectomy to remove the opacity, or phototherapeutic keratectomy (PTK) using an excimer laser. Management of underlying conditions (e.g., treating uveitis or systemic disorders) is also essential.

Prognosis and Follow-Up

Prognosis varies based on the extent of corneal involvement and the success of treatment. Early intervention may improve visual outcomes, but recurrence is possible if underlying causes are not addressed. Regular follow-up with an ophthalmologist is recommended to monitor for progression or recurrence, especially if systemic conditions are present.

Complications

Potential complications include permanent vision loss if the opacity affects the visual axis, corneal scarring, or infection following surgical intervention. Recurrence of band keratopathy may occur if the underlying cause is not managed effectively.

Lifestyle & Prevention

• Manage chronic ocular or systemic conditions as directed by a healthcare provider.
• Avoid prolonged use of topical medications unless prescribed.
• Protect the eyes from trauma and use appropriate safety measures during activities with eye injury risk.
• Maintain regular eye examinations, especially if risk factors are present.

When to Seek Professional Help

Seek prompt medical attention if you experience sudden or worsening vision changes, increased eye pain, or visible changes in the cornea. Early evaluation is important to prevent permanent vision loss and address underlying causes.

Tips for Medical Coders

Use H18.429 for band keratopathy when the eye is not specified. Ensure documentation supports the diagnosis and, if applicable, notes whether the condition is unilateral, bilateral, or associated with systemic factors. Verify that no more specific eye laterality code (e.g., right or left) is applicable before assigning this unspecified code.